Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9

Benzinga · 3d ago
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.